4//SEC Filing
CORNELIUS JAMES M 4
Accession 0000950170-24-107532
CIK 0001776111other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 8:11 PM ET
Size
8.8 KB
Accession
0000950170-24-107532
Insider Transaction Report
Form 4
CORNELIUS JAMES M
Director
Transactions
- Conversion
Common Stock
2024-09-16+102,082→ 102,082 total - Conversion
Series B Convertible Preferred Stock
2024-09-16−233,192→ 0 total→ Common Stock (19,396 underlying) - Conversion
Series A Convertible Preferred Stock
2024-09-16−994,069→ 0 total→ Common Stock (82,686 underlying)
Footnotes (1)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (together, the "Preferred Stock") was convertible into Common Stock on a one-for-12.0221 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on September 16, 2024. The Preferred Stock had no expiration date.
Documents
Issuer
MBX Biosciences, Inc.
CIK 0001776111
Entity typeother
Related Parties
1- filerCIK 0001198959
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 8:11 PM ET
- Size
- 8.8 KB